• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌患者氧化应激、炎症和血管生成标志物的初步研究。

Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.

机构信息

Department of Toxicology, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Borowska Street 211, 50-556, Wrocław, Poland.

Department of Laboratory Diagnostics, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Borowska Street 211a, 50-556, Wrocław, Poland.

出版信息

Pathol Oncol Res. 2020 Apr;26(2):821-831. doi: 10.1007/s12253-019-00620-5. Epub 2019 Mar 4.

DOI:10.1007/s12253-019-00620-5
PMID:30828780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7242270/
Abstract

In recent years, bladder cancer (BC) has been reported as one of the most commonly occurring cancers among older people, and its detection is still difficult. Therefore, there is a need to search for additional useful markers of disease. Some studies indicate the important roles of inflammation and oxidative stress (OS) in bladder tumour pathogenesis. The aim of this study was to examine the levels of selected markers of OS, inflammation and angiogenesis in blood plasma/serum samples derived from patients with BC, and a healthy control group. Moreover the degrees of change and strength of correlation between values of the analysed markers and tumour stage or grade were estimated. Concentrations of: malondialdehyde (MDA) and advanced oxidation protein products (AOPP), and total antioxidant status (TAS) divided into slow (TAS-s) and fast (TAS-f) antioxidants (spectrophotometric measurement), angiogenin (ANG) (immunoenzymatic method) and C-reactive protein (CRP) (immunoturbidimetric method) were determined in both the studied groups. The majority of values of the examined parameters were significantly higher among patients, while subfractions of TAS were significantly lower in comparison to the control group. Moreover, different values and different strengths of correlation between the examined parameters and cancer stage or grade were noticed. The most significant changes for CRP were observed in T2 and for MDA in G3, while the lowest TAS-f activity was revealed in G1 patients. Increased values of OS parameters, angiogenesis and inflammation markers, in combination with reduced TAS subfractions activity in BC are important in its pathogenesis and will be helpful in estimation of patients' condition.

摘要

近年来,膀胱癌(BC)已被报道为老年人中最常见的癌症之一,但其检测仍然困难。因此,需要寻找其他有用的疾病标志物。一些研究表明炎症和氧化应激(OS)在膀胱癌发病机制中起着重要作用。本研究旨在检查来自 BC 患者和健康对照组的血浆/血清样本中 OS、炎症和血管生成的选定标志物的水平。此外,还估计了分析标志物的值与肿瘤分期或分级之间的变化程度和相关性强度。使用分光光度法测定丙二醛(MDA)和高级氧化蛋白产物(AOPP)以及总抗氧化状态(TAS)分为慢速(TAS-s)和快速(TAS-f)抗氧化剂(TAS-s)和快速(TAS-f)抗氧化剂(分光光度法),用免疫酶法测定血管生成素(ANG)和 C 反应蛋白(CRP)(免疫比浊法)。与对照组相比,研究组中大多数检查参数的值明显更高,而 TAS 的亚组分明显更低。此外,还注意到检查参数与癌症分期或分级之间的不同值和不同相关性强度。CRP 的变化最显著是在 T2 期,MDA 的变化最显著是在 G3 期,而 G1 期患者的 TAS-f 活性最低。BC 中 OS 参数、血管生成和炎症标志物的增加值,以及 TAS 亚组分活性的降低,在其发病机制中很重要,并有助于评估患者的病情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e2b/7242270/49a8a53c25a0/12253_2019_620_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e2b/7242270/02bad545865e/12253_2019_620_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e2b/7242270/49a8a53c25a0/12253_2019_620_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e2b/7242270/02bad545865e/12253_2019_620_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e2b/7242270/49a8a53c25a0/12253_2019_620_Fig2_HTML.jpg

相似文献

1
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.膀胱癌患者氧化应激、炎症和血管生成标志物的初步研究。
Pathol Oncol Res. 2020 Apr;26(2):821-831. doi: 10.1007/s12253-019-00620-5. Epub 2019 Mar 4.
2
The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.氧化应激、炎症与血管生成在膀胱癌发展中的相互作用。
Int J Mol Sci. 2021 Apr 25;22(9):4483. doi: 10.3390/ijms22094483.
3
Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes.子宫内膜癌合并糖尿病患者的炎症、氧化应激及抗氧化标志物。
Cytokine. 2019 Aug;120:186-190. doi: 10.1016/j.cyto.2019.05.007. Epub 2019 May 14.
4
Ischemia modified albumin levels and oxidative stress in patients with bladder cancer.膀胱癌患者的缺血修饰白蛋白水平与氧化应激
Asian Pac J Cancer Prev. 2013;14(5):2759-63. doi: 10.7314/apjcp.2013.14.5.2759.
5
Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.膀胱癌患者血清脯氨酸酶活性、氧化应激和一氧化氮水平。
J Cancer Res Clin Oncol. 2012 May;138(5):739-43. doi: 10.1007/s00432-011-1136-4. Epub 2012 Jan 19.
6
Oxidative stress parameters as biomarkers of bladder cancer development and progression.氧化应激参数作为膀胱癌发展和进展的生物标志物。
Sci Rep. 2021 Jul 23;11(1):15134. doi: 10.1038/s41598-021-94729-w.
7
The relationship between interleukin-13 and angiogenin in patients with bladder cancer.膀胱癌患者白细胞介素-13 与血管生成素的关系。
J Physiol Pharmacol. 2021 Aug;72(4). doi: 10.26402/jpp.2021.4.13. Epub 2022 Jan 21.
8
Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer.血清丙二醛(MDA)水平作为膀胱癌患者癌症进展的潜在生物标志物。
Rom J Intern Med. 2020 Sep 1;58(3):146-152. doi: 10.2478/rjim-2020-0008.
9
The evaluation of oxidative stress parameters in breast and colon cancer.评估乳腺癌和结肠癌的氧化应激参数。
Medicine (Baltimore). 2021 Mar 19;100(11):e25104. doi: 10.1097/MD.0000000000025104.
10
Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential.长散在核元件 1 低甲基化与氧化应激:相关性及其在膀胱癌诊断中的潜力。
PLoS One. 2012;7(5):e37009. doi: 10.1371/journal.pone.0037009. Epub 2012 May 15.

引用本文的文献

1
Redox Balance in Cancer in the Context of Tumor Prevention and Treatment.肿瘤预防与治疗背景下癌症中的氧化还原平衡
Biomedicines. 2025 May 9;13(5):1149. doi: 10.3390/biomedicines13051149.
2
The role of angiogenin in bladder cancer: where are we in 2025?血管生成素在膀胱癌中的作用:到2025年我们处于什么阶段?
Int Urol Nephrol. 2025 Apr 22. doi: 10.1007/s11255-025-04517-y.
3
Microbiome and bladder cancer: the role of probiotics in treatment.微生物群与膀胱癌:益生菌在治疗中的作用

本文引用的文献

1
Angiogenesis modulation by exogenous antioxidants.外源性抗氧化剂对血管生成的调节作用。
Cent Eur J Immunol. 2017;42(4):370-376. doi: 10.5114/ceji.2017.72804. Epub 2017 Dec 30.
2
Oxidative Stress in Atherosclerosis.动脉粥样硬化中的氧化应激
Curr Atheroscler Rep. 2017 Sep 18;19(11):42. doi: 10.1007/s11883-017-0678-6.
3
Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.靶向癌细胞的脂质代谢:一种有前景的癌症治疗策略。
Future Microbiol. 2025 Jan;20(1):73-90. doi: 10.1080/17460913.2024.2414671. Epub 2024 Oct 24.
4
Shedding light on the shadows: oxidative stress and its pivotal role in prostate cancer progression.揭示阴影:氧化应激及其在前列腺癌进展中的关键作用。
Front Oncol. 2024 May 7;14:1393078. doi: 10.3389/fonc.2024.1393078. eCollection 2024.
5
Research progress on the structure, function, and use of angiogenin in malignant tumours.血管生成素在恶性肿瘤中的结构、功能及应用研究进展
Heliyon. 2024 May 3;10(9):e30654. doi: 10.1016/j.heliyon.2024.e30654. eCollection 2024 May 15.
6
Chronic Drug-Resistant Cystitis Treated with a Sequence of Modulated Extremely Low-Frequency Electromagnetic Fields: A Randomized Study of 148 Cases.采用调制极低频电磁场序列治疗慢性耐药性膀胱炎:148例随机研究
J Clin Med. 2024 Apr 30;13(9):2639. doi: 10.3390/jcm13092639.
7
Redox System and Oxidative Stress-Targeted Therapeutic Approaches in Bladder Cancer.膀胱癌中的氧化还原系统与氧化应激靶向治疗方法
Antioxidants (Basel). 2024 Feb 26;13(3):287. doi: 10.3390/antiox13030287.
8
A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study.高级氧化蛋白产物(AOPPs)作为评估早期乳腺癌患者预后的潜在方法及其在肿瘤血管生成中的意义的初步评估:一项为期7年的单中心研究
Cancers (Basel). 2024 Mar 6;16(5):1068. doi: 10.3390/cancers16051068.
9
Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings.淋巴瘤患者氧化还原状态与高密度脂蛋白亚类分析及其与氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)结果的相关性
Front Oncol. 2023 Oct 30;13:1221414. doi: 10.3389/fonc.2023.1221414. eCollection 2023.
10
Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.基于铜死亡相关长非编码 RNA 的膀胱癌预后风险模型的构建。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Apr 25;52(2):139-147. doi: 10.3724/zdxbyxb-2022-0539.
Cancer Lett. 2017 Aug 10;401:39-45. doi: 10.1016/j.canlet.2017.05.002. Epub 2017 May 17.
4
Updates of the role of oxidative stress in the pathogenesis of ovarian cancer.氧化应激在卵巢癌发病机制中的作用的最新进展。
Gynecol Oncol. 2017 Jun;145(3):595-602. doi: 10.1016/j.ygyno.2017.02.033. Epub 2017 Feb 23.
5
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges.通过测量生物样品中的丙二醛(MDA)及相关物质评估脂质过氧化:分析和生物学挑战。
Anal Biochem. 2017 May 1;524:13-30. doi: 10.1016/j.ab.2016.10.021. Epub 2016 Oct 24.
6
Role of angiogenesis in urothelial bladder carcinoma.血管生成在膀胱尿路上皮癌中的作用。
Cent European J Urol. 2016;69(3):258-263. doi: 10.5173/ceju.2016.830. Epub 2016 Jul 13.
7
[The role of oxidative stress in bladder cancer].[氧化应激在膀胱癌中的作用]
Postepy Hig Med Dosw (Online). 2015 Jul 6;69:744-52. doi: 10.5604/17322693.1160361.
8
Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway.血管生成素的下调通过调节AKT/mTOR信号通路抑制人膀胱癌细胞的生长并诱导其凋亡。
J Mol Histol. 2015 Apr;46(2):157-71. doi: 10.1007/s10735-014-9608-x. Epub 2015 Jan 7.
9
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.欧洲癌症发病率和死亡率模式:2012 年 40 个国家的估计数。
Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.
10
Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.C 反应蛋白在泌尿系统癌症中的作用:一种预测结果的有用生物标志物。
Int J Urol. 2013 Feb;20(2):161-71. doi: 10.1111/j.1442-2042.2012.03121.x. Epub 2012 Aug 16.